| dc.contributor.author | Kalincik, T. | |
| dc.contributor.author | Horakova, D. | |
| dc.contributor.author | Spelman, T. | |
| dc.contributor.author | Jokubaitis, V. | |
| dc.contributor.author | Trojano, M. | |
| dc.contributor.author | Lugaresi, A. | |
| dc.contributor.author | Bergamaschi, R. | |
| dc.date.accessioned | 2020-06-21T13:56:50Z | |
| dc.date.available | 2020-06-21T13:56:50Z | |
| dc.date.issued | 2014 | |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/15031 | |
| dc.description | Joint ACTRIMS-ECTRIMS Meeting -- SEP 10-13, 2014 -- Boston, MA | en_US |
| dc.description | Oreja-Guevara, Celia/0000-0002-9221-5716; Slee, Mark/0000-0003-4323-2453; Havrdova, Eva Kubala/0000-0002-9543-4359; Lugaresi, Alessandra/0000-0003-2902-5589; Horakova, Dana/0000-0003-1915-0036; McCombe, Pamela/0000-0003-2704-8517 | en_US |
| dc.description | WOS: 000354441300452 | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | ACTRIMS, ECTRIMS | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 20 | en_US |
| dc.identifier.startpage | 195 | en_US |
| dc.identifier.endpage | 196 | en_US |
| dc.relation.journal | Multiple Sclerosis Journal | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
